Metabolism

Items 121-130 of 174

per page
Set Descending Direction
  1. anti-NQO1 (human), pAb
    AG-25A-0105
    AG-25A-0105-C100100 µg
    CHF 190.00
    Western blot analysis using anti-NQO1 (human), pAb (Prod. No. AG-25A-0105) at 1:2'000 dilution.
1: Human NQO1 (His-tagged).
2: HepG2 cell lysate.
3: Unrelated protein (His-tagged) (negative control).
  2. anti-Obestatin (human), pAb
    AG-25A-0043
    AG-25A-0043-C100100 µg
    CHF 190.00
    ELISA (indirect: 1:20’000.): Analysis of production of anti-Obestatin (human), pAb (Prod. No. AG-25A-0043) after peptide immunization.
  3. anti-Omentin (human), mAb (Lecty-1)
    AG-20B-0031
    AG-20B-0031-C100100 µg
    CHF 190.00
  4. anti-Omentin (human), pAb
    AG-25A-0051
    AG-25A-0051-C100100 µg
    CHF 190.00
    Indirect ELISA of recombinant humen Omentin & synthetic human Nampt peptide (control)  using anti-Omentin (human), pAb (Prod. No. AG-25A-0051) at 1:50,000 dilution.
  5. anti-PARP-1 [ARTD1] (human), pAb
    AG-25T-0002
    AG-25T-0002-R100100 µl
    CHF 280.00
  6. anti-PARP-1 [ARTD1] (mouse), pAb
    AG-25T-0001
    AG-25T-0001-R100100 µl
    CHF 340.00
  7. anti-PARP-10 [ARTD10] (human), mAb (5H11)
    AG-20T-0004
    AG-20T-0004-L0011 ml
    CHF 380.00
    Immunofluorescence using anti-PARP-10 [ARTD10] (human), mAb (5H11). Method: T47D mammary carcinoma cells were stained by indirect immunofluorescence and analysed. Prior to fixation and staining, the cells were treated with or without 50nm leptomyci
  8. anti-PARP-2 [ARTD2] (mouse), pAb
    AG-25T-0003
    AG-25T-0003-R100100 µl
    CHF 350.00
  9. anti-PEDF (human), mAb (rec.) (Serpy-1-4)
    AG-27B-0014
    AG-27B-0014-C100100 µg
    CHF 360.00
    Structure of the recombinant antibody anti-PEDF (human), mAb) (rec.) (Serpy-1-4) (Prod. No. AG-27B-0014). The single chain variable human fragment (ScFv) selected by antibody phage display technology and specific to the antigen of interest is fused to a h

Items 121-130 of 174

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.